Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of reparixin on long-term outcomes after pancreatic islet transplantation (extension of REP0110)
2013-002244-86Phase 2Completed
- Sponsor
- Dompé
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of reparixin in diabetes mellitus type 1 (T1D), sponsored by Dompé. Primary endpoint: Long-term efficacy of reparixin on pancreatic islet allotransplantation outcomes. Started Jun 2013; status: completed.
02
Drugs
reparixin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2013-002244-86.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002244-86.